SeaBeLife
SeaBeLife is a drug developer aiming to block cell necrosis founded in 2019 by Morgane Rousselot.
Country
Email Address
Founded Date
2019
Headquarters
Industry
Latest Funding Round Date
October 1, 2025
Latest Funding Round Amount (USD)
2,350,000
Latest Funding Type
LinkedIn URL
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
3,650,000
Twitter URL
Official Website
Find more companies like SeaBeLife
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.